This article is about increased activity and resistance in muscles. For increased blood pressure, see Hypertension.
Not to be confused with muscular hypertrophy.
| Hypertonia |
| Classification and external resources |
| ICD-10 |
P94.1 |
| ICD-9 |
358, 779.89 |
| DiseasesDB |
20872 |
| MeSH |
D009122 |
Hypertonia is a term sometimes used synonymously with spasticity in the literature surrounding damage to the central nervous system, namely upper motor brain lesions.[1] Impaired ability of damaged motor neurons to regulate descending pathways gives rise to disordered spinal reflexes, increased excitability of muscle spindles, and decreased synaptic inhibition.[2] These consequences result in abnormally increased muscle tone of symptomatic muscles.[3] Some authors suggest that the current definition for spasticity, the velocity-dependent over-activity of the stretch reflex, is not sufficient as it fails to take into account patients exhibiting increased muscle tone in the absence of stretch reflex over-activity. They instead suggest that “reversible hypertonia” is more appropriate and represents a treatable condition that is responsive to various therapy modalities like drug and/or physical therapy.[4]
Symptoms associated with central nervous systems disorders are classified into positive and negative categories. Positive symptoms include those that increase muscle activity through hyper-excitability of the stretch reflex (i.e., rigidity and spasticity) where negative symptoms include those of insufficient muscle activity (i.e. weakness) and reduced motor function.[5] Often the two classifications are thought to be separate entities of a disorder; however, some authors propose that they may be closely related.[6]
Contents
- 1 Pathophysiology
- 2 Management
- 2.1 Physical interventions
- 2.2 Pharmaceutical interventions
- 3 See also
- 4 References
- 5 External links
Pathophysiology
Hypertonia is caused by upper motor neuron lesions which may result from injury, disease, or conditions that involve damage to the central nervous system. Motor neuronal hyperactivity occurs due to loss of inhibition of cells of the anterior horn of the spinal cord resulting from reticulospinal tract damage. Different patterns of muscle weakness or hyperactivity can occur based on the location of the lesion, causing a multitude of neurological symptoms, including spasticity, rigidity, or dystonia.[7]
Spastic hypertonia involves uncontrollable muscle spasms, stiffening or straightening out of muscles, shock-like contractions of all or part of a group of muscles, and abnormal muscle tone. It is seen in disorders such as cerebral palsy, stroke, and spinal cord injury. Rigidity is a severe state of hypertonia where muscle resistance occurs throughout the entire range of motion of the affected joint independent of velocity. It is frequently associated with lesions of the basal ganglia. Individuals with rigidity present with stiffness, decreased range of motion and loss of motor control. Dystonic hypertonia refers to muscle resistance to passive stretching (in which a therapist gently stretches the inactive contracted muscle to a comfortable length at very low speeds of movement) and a tendency of a limb to return to a fixed involuntary (and sometimes abnormal) posture following movement.
Management
Therapeutic interventions are best individualized to particular patients.
Basic principles of treatment for hypertonia are to 1) avoid noxious stimuli and 2) provide frequent range of motion exercise.
Physical interventions
Physiotherapy has been shown to be effective in controlling hypertonia through the use of stretching aimed to reduce motor neuron excitability.[8] The aim of each physical therapy session will be to inhibit excessive tone as far as possible, give the patient a sensation of normal position and movement, and to facilitate normal movement patterns. While static stretch has been the classical means to increase range of motion, PNF stretching has been used in many clinical settings to effectively reduce muscle spasticity.[9]
Icing and other topical anesthetics may decrease the reflexive activity for short period of time in order to facilitate motor function. Inhibitory pressure (applying firm pressure over muscle tendon), promoting body heat retention, rhythmic rotation (slow repeated rotation of affected body part to stimulate relaxation)[10] have also been proposed as potential methods to decrease hypertonia. Aside from static stretch casting and splinting techniques are extremely valuable to extend joint range of motion lost to hypertonicity[11] A more unconventional method for limiting tone is to deploy quick repeated passive movements to an involved joint in cyclical fashion; this has also been demonstrated to show results on persons without physical disabilities.[8] For a more permanent state of improvement, exercise and patient education is imperative.[10] Isokinetic,[12][13][14][15] aerobic,[16][17][18] and strength training[19][20][21][22] exercises should be performed as prescribed by a physiotherapist, and stressful situations that may cause increased tone should be minimized or avoided.[10]
Pharmaceutical interventions
Baclofen, diazepam and dantrolene remain the three most commonly used pharmacologic agents in the treatment of spastic hypertonia. Baclofen is generally the drug of choice for spinal cord types of spasticity, while sodium dantrolene is the only agent which acts directly on muscle tissue. Tizanidine is also available. Phenytoin with chlorpromazine may be potentially useful if sedation does not limit their use. Ketazolam, not yet available in the United States, may be a significant addition to the pharmacologic armamentarium. Intrathecal administration of antispastic medications allows for high concentrations of drug near the site of action, which limits side effects.[11]
See also
- Dystonia
- Hypotonia
- Spasticity
- Clasp-knife response
References
- ^ http://www.ninds.nih.gov/disorders/hypertonia/hmypertonia.htm
- ^ O'Sullivan, Susan (2007). Physical Rehabilitation. Philadelphia, PA: F.A Davis Company. p. 234.
- ^ Sheean, G. & McGuire, J. R. (2009). Spastic hypertonia and movement disorders; Pathophysiology, clinical presentation, and quantification. American Academy of Physical Medicine of Rehabilitation, 1, 827-833.
- ^ Bakeheit, A. M. O, Fheodoroff, K. & Molteni, F. (2011). Spasticity or reversible muscle hypertonia? Journal of Rehabilitation Medicine, 43, 556-557.
- ^ Sanger, T. D., Chen, D., Delgado, M. R., Gaebler-Spira, D., Hallett, M., & Mink, J. W., (2006). Definition and classification of negative motor signs in childhood. Pediatrics, 118, 2159-2167
- ^ Damiano DL, Dodd K, Taylor NF. Should we be testing and training muscle strength in cerebral palsy? Dev Med Child Neurol. 2002;44:68 –72
- ^ Geoffrey Sheean, MD, John R. McGuire, MD (2009) Spastic Hypertonia and Movement Disorders: Pathophysiology, Clinical Presentation, and Quantification
- ^ a b Chang, Y. -J.; Fang, C. -Y.; Hsu, M. -J.; Lien, H. -Y.; Wong, M. -K. (2007). "Decrease of hypertonia after continuous passive motion treatment in individuals with spinal cord injury". Clinical Rehabilitation 21 (8): 712–718. doi:10.1177/0269215507079137. PMID 17846071. edit
- ^ Sharman, M. J., Cresswell, A. G., & Riek, S. (2006). Proprioceptive Neuromuscular Facilitation Stretching. Sports Medicine, 36, 929-939.
- ^ a b c O'Sullivan, Susan (2007). Physical Rehabilitation. Philadelphia, PA: F.A Davis Company. p 497.
- ^ a b Katz, R. (1988). Management of spasticity. American Journal of Physical Medicine & Rehabilitation, 67(3), 108-116.
- ^ Giuliani, C: The relationship of spasticity to movement and consideration for therapeutic interventions. Neurol Report (now JNPT) 21:78, 1997.
- ^ Light, K, and Giuliane, C: Effect of isokinetic exercise effort on arm coordination of spastic hemiparetic subjects. Neurology Report (now JNPT) 16:19, 1992.
- ^ Giuliani, C, Light, K, and Rose, D: The effects of isokinetic exercise program in gait patterns of patients with hemiparesis. Neurology Report (now JNPT) 4:23, 1993.
- ^ Brown, D, and Kautz, S: Increased workload enhances force output during pedaling exercise in persons with post stroke hemiplegia. Stroke 29:598, 1998.
- ^ Hunter, M, Tomberlin, J, and Kuna, S: Progressive exercise testing in closed head-injured subjects comparison of exercise apparatus in assessment of a physical conditioning program. Phys Ther 70:363, 1990.
- ^ Jankowski, LW, and Sullivan, SJ: Aerobic and neuromuscular training: Effect on the capacity efficiency and fatigability of patients with traumatic brain injuries. Arch Phys Med Rehab 71 (7): 500, 1990
- ^ Potempa, K, et al: Physiologic outcomes of aerobic exercise training in hemiparetic stroke patients. Stroke 26:101, 1995.
- ^ Damiano, D, and Abel, M: Functional outcomes of strength training in spastic cerebral palsy. Arch Phys Med Rehabil 79:119, 1998. Damiano, D.; Abel, M. F. (1998). "Functional outcomes of strength training in spastic cerebral palsy*1, *2". Archives of Physical Medicine and Rehabilitation 79 (2): 119–125. doi:10.1016/S0003-9993(98)90287-8. PMID 9473991. edit
- ^ Damiano, D, Vaughan, C, and Abel, M: Muscle response to heavy resistance exercise in children with spastic cerebral palsy. Dev Med Child Neurol 38:731, 1995 Damiano, D. L.; Vaughan, C. L.; Abel, M. E. (2008). "Muscle Response to Heavy Resistance Exercise in Children with Spastic Cerebral Palsy". Developmental Medicine & Child Neurology 37 (8): 731–739. doi:10.1111/j.1469-8749.1995.tb15019.x. edit
- ^ Miller, G, Light, K, and Kellog, R: Comparison of isometric force control measures in spastic muscle of post-stroke individuals before and after graded resistive exercise. Neurol Report 20:92, 1996
- ^ Hall, C, and Light, K: Heavy restrictive exercise effect on reciprocal movement coordination of closed-head injured subjects with spasticity. Neurology Report (now JNPT) 14:19, 1990.
External links
- "The Clasp Knife Phenomenon" at mcg.edu
|
Diseases of myoneural junction and muscle / neuromuscular disease (G70–G73, 358–359)
|
|
Neuromuscular-
junction disease |
- autoimmune
- Myasthenia gravis
- Lambert–Eaton myasthenic syndrome
|
|
Myopathy/
congenital myopathy |
Muscular dystrophy
(DAPC) |
| AD |
- Limb-girdle muscular dystrophy 1
- Oculopharyngeal
- Facioscapulohumeral
- Myotonic
- Distal (most)
|
|
| AR |
- Limb-girdle muscular dystrophy 2
- Congenital
- Fukuyama
- Ullrich
- Walker–Warburg
|
|
| XR |
- dystrophin
- Emery–Dreifuss
|
|
|
| Other structural |
- collagen disease
- PTP disease
- adaptor protein disease
- BIN1-linked centronuclear myopathy
- cytoskeleton disease
- Nemaline myopathy
- Zaspopathy
|
|
| Channelopathy |
| Myotonia |
- Myotonia congenita
- Thomsen disease
- Neuromyotonia/Isaacs syndrome
- Paramyotonia congenita
|
|
| Periodic paralysis |
|
|
| Other |
|
|
|
| Mitochondrial myopathy |
|
|
| Other |
|
|
|
|
Index of muscle
|
|
| Description |
- Anatomy
- head
- neck
- arms
- chest and back
- diaphragm
- abdomen
- genital area
- legs
- Muscle tissue
- Physiology
|
|
| Disease |
- Myopathy
- Soft tissue
- Connective tissue
- Congenital
- abdomen
- muscular dystrophy
- Neoplasms and cancer
- Injury
- Symptoms and signs
|
|
| Treatment |
- Procedures
- Drugs
- anti-inflammatory
- muscle relaxants
|
|
|
|
Certain conditions originating in the perinatal period / fetal disease (P, 760–779)
|
|
Maternal factors and
complications of pregnancy,
labour and delivery |
| placenta: |
- Placenta praevia
- Placental insufficiency
- Twin-to-twin transfusion syndrome
|
|
| chorion/amnion: |
|
|
| umbilical cord: |
- Umbilical cord prolapse
- Nuchal cord
- Single umbilical artery
|
|
|
Length of gestation
and fetal growth |
- Small for gestational age/Large for gestational age
- Preterm birth/Postmature birth
- Intrauterine growth restriction
|
|
| Birth trauma |
- scalp
- Cephalhematoma
- Chignon
- Caput succedaneum
- Subgaleal hemorrhage
- Brachial plexus lesion
- Erb's palsy
- Klumpke paralysis
|
|
| By system |
| Respiratory |
- Intrauterine hypoxia
- Infant respiratory distress syndrome
- Transient tachypnea of the newborn
- Meconium aspiration syndrome
- pleural disease
- Pneumothorax
- Pneumomediastinum
- Wilson–Mikity syndrome
- Bronchopulmonary dysplasia
|
|
| Cardiovascular |
- Pneumopericardium
- Persistent fetal circulation
|
|
Haemorrhagic and
hematologic disease |
- Vitamin K deficiency
- Haemorrhagic disease of the newborn
- HDN
- ABO
- Anti-Kell
- Rh c
- Rh D
- Rh E
- Hydrops fetalis
- Hyperbilirubinemia
- Kernicterus
- Neonatal jaundice
- Velamentous cord insertion
- Intraventricular hemorrhage
- Germinal matrix hemorrhage
- Anemia of prematurity
|
|
| Digestive |
- Ileus
- Necrotizing enterocolitis
- Meconium peritonitis
|
|
Integument and
thermoregulation |
- Erythema toxicum
- Sclerema neonatorum
|
|
| Nervous system |
- Periventricular leukomalacia
|
|
| Musculoskeletal |
- Gray baby syndrome
- muscle tone
- Congenital hypertonia
- Congenital hypotonia
|
|
|
| Infectious |
- Vertically transmitted infection
- Congenital rubella syndrome
- Neonatal herpes simplex
- Omphalitis
- Neonatal sepsis
- Group B streptococcal infection
- Neonatal conjunctivitis
|
|
| Other |
- Perinatal mortality
- Stillbirth
- Infant mortality
- Neonatal withdrawal
|
|
|
Index of developmental medicine
|
|
| Description |
- Embryology
- Cell lines
- endoderm
- mesoderm
- ectoderm
|
|
| Disease |
- Due to toxins
- Syndromes
- Chromosomal
- Neonate
- Twins
|
|
Index of obstetrics
|
|
| Description |
- Pregnancy
- Development
- Anatomy
|
|
| Disease |
- Pregnancy and childbirth
- Placenta and neonate
- Infections
- Symptoms and signs
|
|
| Treatment |
- Procedures
- Drugs
- oxytocins
- labor repressants
|
|
|